Director Echelard Yann sold TG Therapeutics ($TGTX) shares on the open market twice in the past year, for a total of $532,250. His most recent sale occurred on November 24, 2025. These transactions rank 6,302nd among 11,678 insiders, well below the average sale amount of $8.6 million across 6.4 transactions per insider. Yann made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 24, 2025 | TG THERAPEUTICS, INC. | $TGTX | Echelard Yann | Director | S | Common Stock | 5000 | $32.57 | 223,816.0000 | 162,102,373 | 2.19% | 0.00% |
| June 12, 2025 | TG THERAPEUTICS, INC. | $TGTX | Echelard Yann | Director | A | Common Stock | 14718 | $0.00 | 238,816.0000 | 160,336,051 | 6.57% | 0.01% |
| June 13, 2025 | TG THERAPEUTICS, INC. | $TGTX | Echelard Yann | Director | S | Common Stock | 10000 | $36.94 | 228,816.0000 | 160,336,051 | 4.19% | 0.01% |
| Nov. 5, 2024 | TG THERAPEUTICS, INC. | $TGTX | Echelard Yann | Director | S | Common Stock | 20000 | $24.48 | 224,098.0000 | 160,714,388 | 8.19% | 0.01% |
| June 19, 2024 | TG THERAPEUTICS, INC. | $TGTX | Echelard Yann | Director | A | Common Stock | 22250 | $0.00 | 244,098.0000 | 148,508,465 | 10.03% | 0.01% |